Literature DB >> 17979720

TFF (trefoil factor family) peptides and their potential roles for differentiation processes during airway remodeling.

Werner Hoffmann1.   

Abstract

Several lines of defense maintain the surface integrity of the delicate airway epithelium which is regularly subjected to severe trauma. These defense mechanisms include protection by the mucus layer, rapid repair by restitution (cell migration) and regeneration via proliferation and differentiation. Luminal surveillance peptides such as epidermal growth factor (EGF) and trefoil factor family (TFF) peptides support synergistically these processes. TFFs are well known particularly for their key role in mucosal restitution and there is an increasing body of evidence that TFFs also support mucosal differentiation processes. Mucus overproduction during inflammatory and obstructive airway diseases is a partial consequence of an increase in the number of goblet cells due to cell division (goblet cell hyperplasia) or differentiation (goblet cell metaplasia). Particularly the latter process reflects the plasticity of the airway epithelium and causes intense airway remodeling. Goblet cells are derived, at least in part, from Clara cells, which trans-differentiate from a serous into a mucous phenotype. This process is critically dependent upon IL-13. In a recent report (Kouznetsova et al. AJRCMB 36:286-297, 2007) using a murine asthma model it was shown that trans-differentiating Clara cells specifically express Tff1 which is stored in a specific subset of secretory granules. This points to a role for Tff1 as an autocrine factor for the trans-differentiation of Clara cells toward goblet cells. Such a role of TFFs for differentiation processes of the airways is supported by another recent study (LeSimple et al. AJRCMB 36:296-303, 2007) where induction of TFF3 synthesis was shown with differentiation in in vivo humanized tracheal xenograft and in vitro air-liquid interface culture models. Furthermore, exogenous TFF3 promoted differentiation of ciliated cells in an EGF receptor-dependent manner. Taken together, both studies imply that TFFs may play key roles for various differentiation processes of the airways and they could be promising novel targets in order to treat severe chronic and acute airway diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17979720     DOI: 10.2174/092986707782023226

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  14 in total

1.  Localization of trefoil factor family peptide 3 (TFF3) in epithelial tissues originating from the three germ layers of developing mouse embryo.

Authors:  Nikola Bijelić; Tatjana Belovari; Maja Tolušić Levak; Mirela Baus Lončar
Journal:  Bosn J Basic Med Sci       Date:  2017-08-20       Impact factor: 3.363

2.  Dietary kaempferol suppresses inflammation of dextran sulfate sodium-induced colitis in mice.

Authors:  Mi-Young Park; Geun Eog Ji; Mi-Kyung Sung
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

3.  Airway trefoil factor expression during naphthalene injury and repair.

Authors:  Melanie A Greeley; Laura S Van Winkle; Patricia C Edwards; Charles G Plopper
Journal:  Toxicol Sci       Date:  2009-10-30       Impact factor: 4.849

4.  Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for allergic airways disease.

Authors:  K P Patel; A S Giraud; C S Samuel; S G Royce
Journal:  Br J Pharmacol       Date:  2016-05-05       Impact factor: 8.739

5.  The pulmonary metatranscriptome prior to pediatric HCT identifies post-HCT lung injury.

Authors:  Matt S Zinter; Caroline A Lindemans; Birgitta A Versluys; Madeline Y Mayday; Sara Sunshine; Gustavo Reyes; Marina Sirota; Anil Sapru; Michael A Matthay; Sandhya Kharbanda; Christopher C Dvorak; Jaap J Boelens; Joseph L DeRisi
Journal:  Blood       Date:  2021-03-25       Impact factor: 22.113

6.  Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice.

Authors:  E Buache; N Etique; F Alpy; I Stoll; M Muckensturm; B Reina-San-Martin; M P Chenard; C Tomasetto; M C Rio
Journal:  Oncogene       Date:  2011-02-28       Impact factor: 9.867

7.  RNA-Seq quantification of the human small airway epithelium transcriptome.

Authors:  Neil R Hackett; Marcus W Butler; Renat Shaykhiev; Jacqueline Salit; Larsson Omberg; Juan L Rodriguez-Flores; Jason G Mezey; Yael Strulovici-Barel; Guoqing Wang; Lukas Didon; Ronald G Crystal
Journal:  BMC Genomics       Date:  2012-02-29       Impact factor: 3.969

8.  Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma.

Authors:  Qing-Yun Chong; Ming-Liang You; Vijay Pandey; Arindam Banerjee; Yi-Jun Chen; Han-Ming Poh; Mengyi Zhang; Lan Ma; Tao Zhu; Salundi Basappa; Liang Liu; Peter E Lobie
Journal:  Oncotarget       Date:  2017-06-09

Review 9.  Trefoil Factor Family (TFF) Peptides and Their Links to Inflammation: A Re-evaluation and New Medical Perspectives.

Authors:  Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

10.  Kinetic characterization of an intestinal trefoil factor receptor.

Authors:  Zhang Yong; Wang Lin; Sun Yong; Liang Guang-Ping; Wu Dan; Lv Shang-Jun; Wu Wei; Peng Xi
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.